<DOC>
	<DOCNO>NCT03007550</DOCNO>
	<brief_summary>This CLASS02-01 trial prospective , multicenter trial laparoscopic total gastrectomy ( LTG ) open total gastrectomy ( OTG ) patient clinical stage I ( T1N0M0、T1N1M0、T2N0M0 ) gastric cancer . The primary purpose study evaluate early operative morbidity mortality determine safety LTG compare OTG clinical stage I gastric adenocarcinoma . The second purpose evaluate recovery course compare postoperative hospital stay patient enrol study .</brief_summary>
	<brief_title>Study On Safety Of Laparoscopic Total Gastrectomy For Clinical Stage I Gastric Cancer</brief_title>
	<detailed_description>Gastric cancer important health problem , fourth common cancer third lead cause cancer-related death worldwide . Age standardized mortality rate gastric cancer 14.3 per 100 000 men 6.9 per 100 000 woman . Incidence show clear regional sex variations-rates high Eastern Asia , Eastern Europe , South America low Northern Southern Africa . More 679 000 new case 498,000 death occur every year China , increase trend proximal gastric cancer observe past year . More 20 year introduction laparoscopic gastrectomy , many large-scale randomized control trial conduct Japan ( JCOG0912 JLSSG0901 ) , Korea ( KLASS01 KLASS02 ) , China ( CLASS01 ) . These trial design evaluate non-inferiority laparoscopic-assisted distal gastrectomy ( LADG ) open counterpart . No RCT laparoscopic total gastrectomy ( LTG ) exist moment . The standardization techniques esophagojejunal anastomosis LTG difficult even experienced surgeon . At present , Japan ( JCOG1401 ) , Korea ( KLASS03 ) , Netherlands ( STOMACH ) plan launch clinical study LTG . China one country high incidence gastric cancer surgeon accumulate extensive experience CLASS01 study . So , 's time conduct clinical research safety LTG gastric cancer . This CLASS02-01 trial prospective , multicenter trial LTG open total gastrectomy ( OTG ) patient clinical stage I ( T1N0M0、T1N1M0、T2N0M0 ) gastric cancer . The primary purpose study evaluate early operative morbidity mortality determine safety LTG compare OTG clinical stage I gastric adenocarcinoma . The second purpose evaluate recovery course compare postoperative hospital stay patient enrol study .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . Aged 1875 years； 2 . Primary lesion pathologically diagnose gastric adenocarcinoma , papillary adenocarcinoma , tubular adenocarcinoma , mucinous adenocarcinoma , poorly cohesive carcinoma ( include signet ring cell carcinoma variant ) , mixed adenocarcinoma ; 3 . Clinical stage IA ( T1N0M0 ) IB ( T1N1M0 , T2N0M0 ) ( According AJCC7th TNM stag system ) ; 4 . Tumor locate upper middle third stomach , curative resection expect achievable total gastrectomy D1+/D210 lymphadenectomy ( also apply multiple primary cancer ) ; 5 . No invasion Zline ; 6 . BMI ( Body Mass Index ) ＜ 30 kg/m2 ; 7 . No history upper abdominal surgery ( except laparoscopic cholecystectomy ) ; 8 . No prior treatment chemotherapy , radiotherapy , target therapy , immunotherapy , etc . ; 9 . No enlargement splenic hilar lymph node ; 10 . Preoperative performance status ( ECOG，Eastern Cooperative Oncology Group ) 0 1 ; 11 . Preoperative ASA ( American Society Anesthesiologists ) scoring : IIII ; 12 . Sufficient organ function ; 13 . Written informed consent . 1 . Preoperative examination indicate stage disease stage II/III/IV ; 2 . Preoperative examination indicate enlargement perigastric retroperitoneal lymph node ( min diameter≥1.0cm ) ; 3 . Women pregnancy breastfeeding ; 4 . Synchronous metachronous ( within 5 year ) malignancy ; 5 . Body temperature ≥ 38℃ surgery infectious disease systemic therapy indicate ; 6 . Severe mental disease ; 7 . Severe respiratory disease ; 8 . Severe hepatic renal dysfunction ; 9 . Unstable angina pectoris history myocardial infarction within 6 month ; 10 . History cerebral infarction cerebral hemorrhage within 6 month ; 11 . Continuous systemic steroid therapy within 1 month ( except topical use ) ; 12 . Gastric cancer complication ( bleed , perforation , obstruction ) require emergency surgery ; 13 . Patients participate participate another clinical trial ( within 6 month ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Gastric cancer</keyword>
	<keyword>Laparoscopic total gastrectomy</keyword>
	<keyword>Open total gastrectomy</keyword>
</DOC>